Roger A. Pedersen
Corporate Officer/Principal bij University of Cambridge
Profiel
Roger A.
Pedersen is the founder of DefiniGEN Ltd.
which was founded in 2012.
Currently, he is a Professor at the University of Cambridge.
Dr. Pedersen completed his undergraduate degree from Stanford University in 1965 and his doctorate degree from Yale University in 1970.
Actieve functies van Roger A. Pedersen
| Bedrijven | Functie | Begin |
|---|---|---|
| University of Cambridge | Corporate Officer/Principal | - |
Eerdere bekende functies van Roger A. Pedersen
| Bedrijven | Functie | Einde |
|---|---|---|
DefiniGEN Ltd.
 DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Oprichter | - |
Opleiding van Roger A. Pedersen
| Stanford University | Undergraduate Degree |
| Yale University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
DefiniGEN Ltd.
DefiniGEN Ltd. Miscellaneous Commercial ServicesCommercial Services DefiniGEN Ltd. provides human cell products to the drug discovery sector. Its services include iPSC Differentiation, Gene Editing, CRISPR Modeling and Patient Derived Models. The firm products include Hepatocytes, Intestinal and Pancreatic. The company was founded in April 2012 by Candy Hsin-Hua Cho, Nicolas R. F. Hannan, Roger A. Pedersen and Tamir Rashid and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
